Impact of reduced ATGL-mediated adipocyte lipolysis on obesity-associated insulin resistance and inflammation in male mice

Endocrinology

Volumn 156, Issue 10, 2015, Pages 3610-3624

  Schoiswohl, Gabriele ^a,e   Stefanovic Racic, Maja ^a   Menke, Marie N ^b   Wills, Rachel C ^a   Surlow, Beth A ^a   Basantani, Mahesh K ^a,f   Sitnick, Mitch T ^a,d   Cai, Lingzhi ^a   Yazbeck, Cynthia F ^a,g   Stolz, Donna B ^a   Pulinilkunnil, Thomas ^c   O'Doherty, Robert M ^a   Kershaw, Erin E ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c DALHOUSIE UNIVERSITY   (Canada)

^d MONTCLAIR STATE UNIVERSITY   (United States)

^e UNIVERSITY OF GRAZ   (Austria)

^f SHRI RAMSWAROOP MEMORIAL UNIVERSITY   (India)

^g VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CRE RECOMBINASE; GLUCOSE; INSULIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; TRIACYLGLYCEROL LIPASE; DIFFERENTIATION ANTIGEN; GLYCOPROTEIN P 15095; LIPID; MONOCYTE-MACROPHAGE DIFFERENTIATION ANTIGEN; PNPLA2 PROTEIN, MOUSE;

ADIPOCYTE; ADIPOGENESIS; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CELL ACTIVATION; CELL INFILTRATION; CONTROLLED STUDY; DIET INDUCED OBESITY; EXPERIMENTAL INFLAMMATION; FAT MASS; FATTY LIVER; FEMALE; GENE DELETION; GLUCOSE BLOOD LEVEL; IN VIVO STUDY; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN TOLERANCE TEST; KNOCKOUT GENE; LIPID OXIDATION; LIPID TRANSPORT; LIPOLYSIS; LIVER; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN HYDROLYSIS; PROTEIN TARGETING; 129 MOUSE; ADVERSE EFFECTS; ANIMAL; BLOOD; C57BL MOUSE; DENDRITIC CELL; GENE EXPRESSION; GENETICS; IMMUNOBLOTTING; INFLAMMATION; KNOCKOUT MOUSE; LIPID DIET; LIPID METABOLISM; MACROPHAGE; METABOLISM; OBESITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADIPOCYTES; ADIPOSE TISSUE; ANIMALS; ANTIGENS, CD11C; ANTIGENS, DIFFERENTIATION; DENDRITIC CELLS; DIET, HIGH-FAT; GENE EXPRESSION; IMMUNOBLOTTING; INFLAMMATION; INSULIN RESISTANCE; LIPASE; LIPID METABOLISM; LIPIDS; LIPOLYSIS; LIVER; MACROPHAGES; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, KNOCKOUT; OBESITY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84943641363     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2015-1322     Document Type: Article

References (50)

1. Samuel VT, Shulman GI. Mechanisms for insulin resistance: common threads and missing links. Cell. 2012;148:852-871.
2. Morris DL, Singer K, Lumeng CN. Adipose tissue macrophages: phenotypic plasticity and diversity in lean and obese states. Curr Opin Clin Nutr Metab Care. 2011;14:341-346.
3. Cinti S, Mitchell G, Barbatelli G, et al. Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res. 2005;46:2347-2355.
4. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 2003;112:1796-1808.
5. Kosteli A, Sugaru E, Haemmerle G, et al. Weight loss and lipolysis promote a dynamicimmuneresponse in murine adipose tissue. J Clin Invest. 2010;120:3466-3479.
6. Mottillo EP, Shen XJ, Granneman JG. β3-adrenergic receptor induction of adipocyte inflammation requires lipolytic activation of stress kinases p38 and JNK. Biochim Biophys Acta. 2010;1801: 1048-1055.
7. Zimmermann R, Strauss JG, Haemmerle G, et al. Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase. Science. 2004;306:1383-1386.
8. Jenkins CM, Mancuso DJ, Yan W, Sims HF, Gibson B, Gross RW. Identification, cloning, expression, and purification of three novel human calcium-independent phospholipase A2 family members possessing triacylglycerol lipase and acylglycerol transacylase activities. J Biol Chem. 2004;279:48968-48975.
9. Villena JA, Roy S, Sarkadi-Nagy E, Kim KH, Sul HS. Desnutrin, an adipocyte gene encoding a novel patatin domain-containing protein, is induced by fasting and glucocorticoids: ectopic expression of desnutrin increases triglyceride hydrolysis. J Biol Chem. 2004;279: 47066-47075.
10. Haemmerle G, Lass A, Zimmermann R, et al. Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase. Science. 2006;312:734-737.
11. Kienesberger PC, Lee D, Pulinilkunnil T, et al. Adipose triglyceride lipase deficiency causes tissue-specific changes in insulin signaling. J Biol Chem. 2009;284:30218-30229.
12. Lettieri Barbato D, Aquilano K, Baldelli S, et al. Proline oxidaseadipose triglyceride lipase pathway restrains adipose cell death and tissue inflammation. Cell Death Differ. 2014;21:113-123.
13. Lettieri Barbato D, Tatulli G, Aquilano K, Ciriolo MR. Inhibition of age-related cytokines production by ATGL: a mechanism linked to the anti-inflammatory effect of resveratrol. Mediators Inflamm. 2014;2014:917698.
14. Varga T, Czimmerer Z, Nagy L. PPARs are a unique set of fatty acid regulated transcription factors controlling both lipid metabolism and inflammation. Biochim Biophys Acta. 2011;1812:1007-1022.
15. Aflaki E, Balenga NA, Luschnig-Schratl P, et al. Impaired Rho GTPase activation abrogates cell polarization and migration in macrophages with defective lipolysis. Cell Mol Life Sci. 2011;68:3933-3947.
16. Aflaki E, Radovic B, Chandak PG, et al. Triacylglycerol accumulation activates the mitochondrial apoptosis pathway in macrophages. J Biol Chem. 2011;286:7418-7428.
17. Chandak PG, Radovic B, Aflaki E, et al. Efficient phagocytosis requires triacylglycerol hydrolysis by adipose triglyceride lipase. J Biol Chem. 2010;285:20192-20201.
18. Ahmadian M, Abbott MJ, Tang T, et al. Desnutrin/ATGL is regulated byAMPKand is required for a brown adipose phenotype. Cell Metab. 2011;13:739-748.
19. Wu JW, Wang SP, Casavant S, Moreau A, Yang GS, Mitchell GA. Fasting energy homeostasis in mice with adipose deficiency of desnutrin/ adipose triglyceride lipase. Endocrinology. 2012;153:2198-2207.
20. Lee KY, Russell SJ, Ussar S, et al. Lessons on conditional gene targeting in mouse adipose tissue. Diabetes. 2013;62:864-874.
21. Jeffery E, Berry R, Church CD, et al. Characterization of Cre recombinase models for the study of adipose tissue. Adipocyte. 2014; 3:206-211.
22. Sitnick MT, Basantani MK, Cai L, et al. Skeletal muscle triacylglycerol hydrolysis does not influence metabolic complications of obesity. Diabetes. 2013;62:3350-3361.
23. Eguchi J, Wang X, Yu S, et al. Transcriptional control of adipose lipid handling by IRF4. Cell Metab. 2011;13:249-259.
24. Basantani MK, Sitnick MT, Cai L, et al. Pnpla3/Adiponutrin deficiency in mice does not contribute to fatty liver disease or metabolic syndrome. J Lipid Res. 2011;52:318-329.
25. Stefanovic-Racic M, Yang X, Turner MS, et al. Dendritic cells promote macrophage infiltration and comprise a substantial proportion of obesity-associated increases inCD11cβcells in adipose tissue and liver. Diabetes. 2012;61:2330-2339.
26. Tomiyama K, Murase N, Stolz DB, et al. Characterization of transplanted green fluorescent proteinβ bone marrow cells into adipose tissue. Stem Cell. 2008;26:330-338.
27. Reilich P, Horvath R, Krause S, et al. The phenotypic spectrum of neutral lipid storage myopathy due to mutations in the PNPLA2 gene. J Neurol. 2011;258:1987-1997.
28. Natali A, Gastaldelli A, Camastra S, et al. Metabolic consequences of adipose triglyceride lipase deficiency in humans: an in vivo study in patients with neutral lipid storage disease with myopathy. J Clin Endocrinol Metab. 2013;98:E1540-E1548.
29. Mottillo EP, Balasubramanian P, Lee YH, Weng C, Kershaw EE, Granneman JG. Coupling of lipolysis and de novo lipogenesis in brown, beige, and white adipose tissues during chronic β3-adrenergic receptor activation. J Lipid Res. 2014;55:2276-2286.
30. Hotamisligil GS, Budavari A, Murray D, Spiegelman BM. Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-β. J Clin Invest. 1994;94: 1543-1549.
31. Huang W, Metlakunta A, Dedousis N, et al. Depletion of liver Kupffer cells prevents the development of diet-induced hepatic steatosis and insulin resistance. Diabetes. 2010;59:347-357.
32. Kang K, Reilly SM, Karabacak V, et al. Adipocyte-derived Th2 cytokines and myeloid PPARβ regulate macrophage polarization and insulin sensitivity. Cell Metab. 2008;7:485-495.
33. Odegaard JI, Ricardo-Gonzalez RR, Red Eagle A, et al. Alternative M2 activation of Kupffer cells by PPARβ ameliorates obesity-induced insulin resistance. Cell Metab. 2008;7:496-507.
34. He W, Barak Y, Hevener A, et al. Adipose-specific peroxisome proliferator-activated receptor β knockout causes insulin resistance in fat and liver but not in muscle. Proc Natl Acad Sci USA. 2003;100: 15712-15717.
35. Perry RJ, Camporez JP, Kursawe R, et al. Hepatic acetyl CoA links adipose tissue inflammation to hepatic insulin resistance and type 2 diabetes. Cell. 2015;160:745-758.
36. Ahmadian M, Duncan RE, Varady KA, et al. Adipose overexpression of desnutrin promotes fatty acid use and attenuates diet-induced obesity. Diabetes. 2009;58:855-866.
37. Ong KT, Mashek MT, Bu SY, Mashek DG. Hepatic ATGL knockdown uncouples glucose intolerance from liver TAG accumulation. FASEB J. 2013;27:313-321.
38. Wu JW, Wang SP, Alvarez F, et al. Deficiency of liver adipose triglyceride lipase in mice causes progressive hepatic steatosis. Hepatology. 2011;54:122-132.
39. Turpin SM, Hoy AJ, Brown RD, et al. Adipose triacylglycerol lipase is a major regulator of hepatic lipid metabolism but not insulin sensitivity in mice. Diabetologia. 2011;54:146-156.
40. Jha P, Claudel T, Baghdasaryan A, et al. Role of adipose triglyceride lipase (PNPLA2) in protection from hepatic inflammation in mouse models of steatohepatitis and endotoxemia. Hepatology. 2014;59: 858-869.
41. Mottillo EP, Shen XJ, Granneman JG. Role of hormone-sensitive lipase in β-adrenergic remodeling of white adipose tissue. Am J Physiol Endocrinol Metab. 2007;293:E1188-E1197.
42. Granneman JG, Li P, Zhu Z, Lu Y. Metabolic and cellular plasticity in white adipose tissue I: effects ofβ3-adrenergic receptor activation. Am J Physiol Endocrinol Metab. 2005;289:E608-E616.
43. Lee YH, Petkova AP, Granneman JG. Identification of an adipogenic niche for adipose tissue remodeling and restoration. Cell Metab. 2013;18:355-367.
44. Hansson O, Ström K, Güner N, et al. Inflammatory response in white adipose tissue in the non-obese hormone-sensitive lipase null mouse model. J Proteome Res. 2006;5:1701-1710.
45. Albert JS, Yerges-Armstrong LM, Horenstein RB, et al. Null mutation in hormone-sensitive lipase gene and risk of type 2 diabetes. N Engl J Med. 2014;370:2307-2315.
46. Strissel KJ, Stancheva Z, Miyoshi H, et al. Adipocyte death, adipose tissue remodeling, and obesity complications. Diabetes. 2007;56: 2910-2918.
47. Tynan GA, Hearnden CH, Oleszycka E, et al. Endogenous oils derived from human adipocytes are potent adjuvants that promote IL-1α-dependent inflammation. Diabetes. 2014;63:2037-2050.
48. Haemmerle G, Moustafa T, Woelkart G, et al. ATGL-mediated fat catabolism regulates cardiac mitochondrial function via PPAR-α and PGC-1. Nat Med. 2011;17:1076-1085.
49. Sapiro JM, Mashek MT, Greenberg AS, Mashek DG. Hepatic triacylglycerol hydrolysis regulates peroxisome proliferator-activated receptor α activity. J Lipid Res. 2009;50:1621-1629.
50. Mottillo EP, Bloch AE, Leff T, Granneman JG. Lipolytic products activate peroxisome proliferator-activated receptor (PPAR) α and δ inbrownadipocytes to match fatty acid oxidation with supply. J Biol Chem. 2012;287:25038-25048.